Stay updated on Amivantamab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.

Latest updates to the Amivantamab in Gastric Cancer Clinical Trial page
- Check4 days agoChange DetectedAdded a new release note 'Revision: v3.3.3' in the page footer. Removed the 'HHS Vulnerability Disclosure' link and the older 'Revision: v3.3.2' release note.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.3.2 has been added and Revision: v3.2.0 has been removed.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page no longer shows the government funding status/operating status notice. This change does not affect the trial details, inclusion criteria, or listed locations.SummaryDifference0.4%

- Check55 days agoChange DetectedNo significant changes to the study details, outcomes, or enrollment are evident; only minor formatting or layout updates appear.SummaryDifference0.4%

- Check83 days agoChange DetectedCore content updated to v3.2.0 with a government funding status notice and operating details; previous v3.1.0 deletion indicates version upgrade.SummaryDifference2%

- Check90 days agoChange Detected- The page version updated from v3.0.2 to v3.1.0, indicating a newer release.SummaryDifference0.0%

Stay in the know with updates to Amivantamab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.